BRIEF published on 08/10/2026 at 09:05, 2 months 25 days ago Rosenbauer International AG Hits Record Order Backlog Amid Delays Innovation Profitability Order Backlog Revenue Decline Rosenbauer
PRESS RELEASE published on 08/10/2026 at 09:00, 2 months 25 days ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY Rosenbauer International AG strengthened profitability with new record order backlog but faced temporary delays in Q2 26. Improved margin and new product innovation showcased. FY26 guidance slightly reduced Product Innovation Profitability Order Backlog Rosenbauer International AG Q2 26
BRIEF published on 05/20/2026 at 09:05, 5 months 15 days ago Rosenbauer International AG Announces Strong Q1 Growth Financial Performance Order Intake Rosenbauer International AG Q1 Growth Vehicle Deliveries
PRESS RELEASE published on 05/20/2026 at 09:00, 5 months 15 days ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY Rosenbauer International AG Q1 results show double-digit growth in orders, revenue, and margin. Strong performance across Asia and Europe drives optimism for FY26 guidance Europe Double-digit Growth Rosenbauer International AG Asia Q1 Results
BRIEF published on 04/13/2026 at 09:05, 6 months 21 days ago Rosenbauer International AG Shows Strong Profit Growth EBIT Margin Profit Growth Efficiency Measures Rosenbauer Financial Results 2026 Projection
PRESS RELEASE published on 04/13/2026 at 09:00, 6 months 21 days ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY Rosenbauer International AG reports record annual results, focusing on efficiency and profitability growth. Increase in net profit, strengthened balance sheet, and outlook for FY26e Profitability Efficiency Rosenbauer International AG Record Annual Results FY26e Outlook
BRIEF published on 02/24/2026 at 09:05, 8 months 8 days ago Rosenbauer International AG Maintains Growth Momentum with Strategic Advances Operational Efficiency Commercial Growth Rosenbauer Technological Leadership PANTHER Vehicle
PRESS RELEASE published on 02/24/2026 at 09:00, 8 months 8 days ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY Rosenbauer International AG shows strong commercial momentum for 2026 with regional expansion, new product orders, and technological advancements. Positive outlook on sales growth and EBITDA improvement Sales Growth Rosenbauer International AG EBITDA Improvement Technological Advancements Commercial Momentum
BRIEF published on 02/13/2026 at 09:05, 8 months 19 days ago Rosenbauer International AG Targets Strong Growth in 2026 Order Backlog EBITDA Increase Electric Vehicle Efficiency Measures Rosenbauer 2026 Growth
PRESS RELEASE published on 02/13/2026 at 09:00, 8 months 19 days ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY Read latest research update on Rosenbauer International AG by NuWays AG. Forecasting 14.8% sales and 29% EBITDA growth in 2026, focused on operational improvements and financial stability Sales Growth NuWays AG Research Update Rosenbauer International AG EBITDA Growth
Published on 11/04/2026 at 23:10, 4 hours 15 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 4 hours 25 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 10 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 5 hours 20 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:10, 15 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 3 hours 23 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 7 hours 44 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 8 hours ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 8 hours 42 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:00, 9 hours 25 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 17:44, 9 hours 41 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Published on 11/04/2026 at 11:56, 15 hours 28 minutes ago Mersen: Number of shares and voting rights as of October 31, 2026
